Bluejay Therapeutics is planning an IPO in the US, targeting $150 million.
Daily NewsBluejay Therapeutics, a pharmaceutical company specializing in severe viral and liver diseases, is reportedly planning an initial public offering (IPO) in the U.S...
Read More